Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026)

Genelux's (GNLX) quarterly Change in Acquisitions & Divestments came in at $6.8 million in Q1 2026, up 13.0% year-on-year from $6.0 million in Q1 2025, and down 3.14% quarter-over-quarter from $7.0 million in Q4 2025.

Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends

Genelux's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 13.0% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $32.3 million, a 25.36% increase from a year earlier, with the FY2025 full-year figure at $31.5 million, up 48.24% from the prior year.
  • Change in Acquisitions & Divestments declined to $6.8 million in Q1 2026 per GNLX's latest filing, from $7.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $10.5 million in Q3 2025 and bottomed at $1.5 million in Q1 2024.
  • The 3-year median for Change in Acquisitions & Divestments is $6.8 million (2026), against an average of $6.6 million.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 300.0% in 2025; the steepest drop was 3.45% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $7.2 million in 2024, then dropped by 3.45% to $7.0 million in 2025, then slipped by 3.14% to $6.8 million in 2026.
  • Per Business Quant, the three latest GNLX Change in Acquisitions & Divestments figures stand at $6.8 million (Q1 2026), $7.0 million (Q4 2025), and $10.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,538.84 Bn 65,538.56 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 469.46 Bn 464.67 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.69 Bn 115.45 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.41 Bn 61.65 Bn 3.31 Bn
7 Belite Bio 62.84 Bn 62.84 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn
10 Genelux 128.92 Mn 128.92 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.78 Mn
Mar 31, 2026 6.78 Mn
Dec 31, 2025 7.00 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 10.50 Mn
Sep 30, 2025 10.50 Mn
Jun 30, 2025 8.00 Mn
Jun 30, 2025 8.00 Mn
Mar 31, 2025 6.00 Mn
Mar 31, 2025 6.00 Mn
Dec 31, 2024 7.25 Mn
Dec 31, 2024 7.25 Mn
Sep 30, 2024 6.00 Mn
Sep 30, 2024 6.00 Mn
Jun 30, 2024 6.50 Mn
Jun 30, 2024 6.50 Mn
Mar 31, 2024 1.50 Mn
Mar 31, 2024 1.50 Mn